ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
129.036,10
-0,07%
S&P 500
5.987,37
0,30%
US Dollar vs BRL
5,799
-0,02%
Bitcoin
93.853,15
0,82%
Brent Oil
72,655
0,07%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. XTL Biopharmaceuticals Ltd (XTLB)

  7. XTL Biopharmaceuticals Ltd (XTLB) Notícias

XTLB

XTL Biopharmaceuticals (XTLB)

XTL Biopharmaceuticals Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:XTLB
DataHoraFonteTítuloCódigoCompanhia
19/11/202419:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XTLBXTL Biopharmaceuticals Ltd
14/08/202410:15GlobeNewswire Inc.XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 MillionNASDAQ:XTLBXTL Biopharmaceuticals Ltd
05/06/202410:15GlobeNewswire Inc.XTL Entered Definitive Agreement to Acquire The Social ProxyNASDAQ:XTLBXTL Biopharmaceuticals Ltd
20/03/202411:15GlobeNewswire Inc.XTL To Aquire The Social ProxyNASDAQ:XTLBXTL Biopharmaceuticals Ltd
20/10/202317:00GlobeNewswire Inc.XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelNASDAQ:XTLBXTL Biopharmaceuticals Ltd
20/10/202317:00GlobeNewswire Inc.XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:XTLBXTL Biopharmaceuticals Ltd
16/05/202312:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
01/02/202311:53Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
30/03/202218:16Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
08/06/202107:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
19/05/202112:31Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
24/08/202010:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
13/01/202008:39Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
01/11/201811:09PR Newswire (US)XTL Biopharmaceuticals Reports Third Quarter 2018 Financial Results and Provides UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
24/07/201810:09PR Newswire (US)XTL Biopharmaceuticals Reports First Half 2018 Financial Results & Provides UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
29/05/201818:37PR Newswire (US)XTL Biopharmaceuticals Reports First Quarter 2018 Financial Results & Provides UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
07/03/201818:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
28/02/201818:04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
05/01/201818:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
06/12/201715:08PR Newswire (US)XTL Biopharmaceuticals Ltd. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Listing RequirementsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
27/11/201713:30PR Newswire (US)XTL Biopharmaceuticals Reports Third Quarter 2017 Financial ResultsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
23/10/201713:23PR Newswire (US)XTL Biopharmaceuticals Receives Notification From NASDAQ Regarding Continuing Listing RequirementsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
26/09/201710:23PR Newswire (US)XTL Biopharmaceuticals Reports First Half 2017 Financial Results & Provides Clinical and Operational UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
12/09/201711:24PR Newswire (US)XTL Biopharmaceuticals Unveils Additional Expanded hCDR1 Preclinical Data for the Treatment of Sjogren's SyndromeNASDAQ:XTLBXTL Biopharmaceuticals Ltd
15/06/201710:38PR Newswire (US)XTL Biopharmaceuticals Reports First Quarter 2017 Financial Results & Provides Clinical and Operational UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
27/04/201710:50PR Newswire (US)XTL Biopharmaceuticals Appoints Mr. Alex Rabinovich to its Board of DirectorsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
05/04/201710:10PR Newswire (US)XTL Biopharmaceuticals Unveils Expanded hCDR1 Preclinical Data for the Treatment of Sjögren’s SyndromeNASDAQ:XTLBXTL Biopharmaceuticals Ltd
30/03/201709:55PR Newswire (US)XTL Biopharmaceuticals Reports 2016 Financial Results & Provides Clinical and Operational UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
29/03/201718:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
22/03/201710:22PR Newswire (US)XTL Biopharmaceuticals Announces Closing of $2.8 Million Private Placement From Existing InvestorsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:XTLB

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
IBOV
Índice Bovespa
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 60%* para TRADER PLUS

1 ano 40%, 2 anos 50% e *3 anos 60%

*Ao longo de 3 anos $ 1475.65 apenas $ 590.25